CompletedNo phase
The Fate of Aortic Valve After SAS Surgery in Children
Key facts
- Who runs it
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 232 people enrolled
- Started
- 1 Jan 2008
- Ended
- 30 Nov 2024
- Type of study
- Observational
- Record updated
- 27 December 2024
Who can take part
- Age
- 0 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age from 0-18
- Clinical diagnosis of subaortic stenosis and underwent surgery
Who cannot take part
- Underwent concomitant previous surgical repair for aortic valve or SAS
- Diagnosed with hypertrophic cardiomyopathy
- Follow-up time less than 1 year or lack of detailed information
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Aortic valve regurgitation (AR) is a common complication following surgery for subaortic stenosis (SAS), yet the long-term outcomes and risk factors for postoperative significant AR (SAR) remain poorly understood. This study aims to investigate the incidence and risk factors of SAR in SAS patients and evaluate the long-term postoperative outcomes.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Aortic Valve Regurgitation After Surgical Repair for Subaortic Stenosis in Children
- Record updated
- 27 December 2024